Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

CTBC Financial (2891.TW)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (NT$)	Price Target (NT$)	Rating
2022-02-28	NaN	27.85	Buy
2022-06-15	26.30	33.10	Buy
2022-09-28	20.10	30.20	Buy
2022-11-18	21.40	30.00	Buy
2023-01-16	23.05	28.70	Buy
2023-05-15	23.35	29.20	Buy
2023-08-19	23.35	29.80	Buy
2023-11-14	26.15	30.60	Buy
2023-12-13	27.95	31.60	Buy
2024-03-13	31.85	33.50	Buy
2024-06-05	36.30	40.50	Buy
2024-09-20	34.00	34.80	Neutral
2025-03-10	40.00	-	No Rating
2025-04-07	36.40	34.80	Neutral
2025-05-23	42.80	47.00	Buy

Disclosures

Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.